131 related articles for article (PubMed ID: 10877571)
1. Cost utility of drugs for multiple sclerosis. Analysis goes too far.
Ellis SJ
BMJ; 2000 May; 320(7247):1475-6. PubMed ID: 10877571
[No Abstract] [Full Text] [Related]
2. Interferon beta produces only small benefits in multiple sclerosis.
McKee L
BMJ; 1998 May; 316(7142):1410. PubMed ID: 9616008
[No Abstract] [Full Text] [Related]
3. Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.
Richards R; Burls A; Payne N
BMJ; 2000 May; 320(7247):1475; author reply 1475-6. PubMed ID: 10877570
[No Abstract] [Full Text] [Related]
4. Beta interferon, NICE, and rationing.
Kernick D
Br J Gen Pract; 2002 Sep; 52(482):784-5. PubMed ID: 12236297
[No Abstract] [Full Text] [Related]
5. Patients' views of explicit rationing: what are the implications for health service decision-making?
Devlin N; Appleby J; Parkin D
J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
[TBL] [Abstract][Full Text] [Related]
6. Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast.
Bryant J; Clegg A; Milne R
BMJ; 2000 May; 320(7247):1474-5; author reply 1475-6. PubMed ID: 10877569
[No Abstract] [Full Text] [Related]
7. The use of interferon beta at the time of initial diagnosis of multiple sclerosis.
Pender MP
J Clin Neurosci; 2001 Jul; 8(4):381-2. PubMed ID: 11437589
[No Abstract] [Full Text] [Related]
8. Interferon beta for treatment of multiple sclerosis.
Wilson BA
Medsurg Nurs; 1995 Apr; 4(2):151-3. PubMed ID: 7711824
[No Abstract] [Full Text] [Related]
9. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?
Hodgkinson SJ
J Clin Neurosci; 2001 Jul; 8(4):378-9. PubMed ID: 11437587
[No Abstract] [Full Text] [Related]
10. 10 years of interferon beta-1b (Beta feron therapy.
Kappos L; Hartung HP
J Neurol; 2005 Sep; 252 Suppl 3():iii1-iii2. PubMed ID: 16170493
[No Abstract] [Full Text] [Related]
11. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
Mikaeloff Y; Moreau T; Debouverie M; Pelletier J; Lebrun C; Gout O; Pedespan JM; Van Hulle C; Vermersch P; Ponsot G
J Pediatr; 2001 Sep; 139(3):443-6. PubMed ID: 11562627
[TBL] [Abstract][Full Text] [Related]
12. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? The case against.
Macdonell R
J Clin Neurosci; 2001 Jul; 8(4):379-81. PubMed ID: 11437588
[No Abstract] [Full Text] [Related]
13. Interferons in multiple sclerosis.
Kappos L
Neurol Clin; 2005 Feb; 23(1):189-214, vii-viii. PubMed ID: 15661094
[No Abstract] [Full Text] [Related]
14. Interferon beta, PHARMAC, and political directives: in the best interests of people with multiple sclerosis?
McNaughton H; Kayes N; McPherson K
N Z Med J; 2006 Apr; 119(1232):U1939. PubMed ID: 16633398
[TBL] [Abstract][Full Text] [Related]
15. Pearls and pitfalls of interferon beta treatment for multiple sclerosis.
Corona T; León C; Ruiz JL
Neurologia; 1999 Nov; 14(9):467-8. PubMed ID: 10613023
[No Abstract] [Full Text] [Related]
16. [High doses of interferon in the treatment of multiple sclerosis].
Muñoz D
Rev Neurol; 2001 May 1-15; 32(9):899. PubMed ID: 11424041
[No Abstract] [Full Text] [Related]
17. [New trends, clinical questions and long-term experiences. Therapy of multiple sclerosis with interferon beta-1b].
Nervenarzt; 1998 Nov; 69(11 Suppl Therapie D):1-8. PubMed ID: 9845885
[No Abstract] [Full Text] [Related]
18. Cost-utility analysis of interferon beta-1B in secondary progressive multiple sclerosis using natural history disease data.
Kobelt G; Jönsson L; Miltenburger C; Jönsson B
Int J Technol Assess Health Care; 2002; 18(1):127-38. PubMed ID: 11987436
[TBL] [Abstract][Full Text] [Related]
19. A cost-utility analysis of interferon beta for multiple sclerosis.
Parkin D; McNamee P; Jacoby A; Miller P; Thomas S; Bates D
Health Technol Assess; 1998; 2(4):iii-54. PubMed ID: 9580870
[No Abstract] [Full Text] [Related]
20. [Betaferon and therapy of multiple sclerosis--present and future].
Hohlfeld R
Med Klin (Munich); 2001 Sep; 96 Suppl 1():1. PubMed ID: 11603109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
